- Home
- CNTY vs IXHL Comparison
CNTY vs IXHL Comparison
Compare CNTY & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTY | IXHL |
|---|---|---|
| Founded | 1992 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0M | 37.0M |
| IPO Year | 1996 | 2024 |
Fundamental Metrics
Financial Performance| Metric | CNTY | IXHL |
|---|---|---|
| Price | $1.27 | $3.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 66.3K | ★ 77.6K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.31 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $430,529,000.00 | $12,000.00 |
| Revenue This Year | $7.17 | N/A |
| Revenue Next Year | $3.28 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 10.82 | N/A |
| 52 Week Low | $1.14 | $0.16 |
| 52 Week High | $2.81 | $6.39 |
Technical Indicators
Market Signals| Indicator | CNTY | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 52.77 | 66.74 |
| Support Level | $1.24 | $2.79 |
| Resistance Level | $1.34 | $3.68 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 56.25 | 94.20 |
Price Performance
Historical ComparisonAbout CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.